Literature DB >> 21852261

Ovarian cancer treatments on the horizon.

Charlie Schmidt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852261     DOI: 10.1093/jnci/djr343

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Overview of cancer vaccines: considerations for development.

Authors:  Alex Kudrin
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 2.  Cancer vaccines: what do we need to measure in clinical trials?

Authors:  Alex Kudrin
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models.

Authors:  P Oliva; A Decio; V Castiglioni; A Bassi; E Pesenti; M Cesca; E Scanziani; D Belotti; R Giavazzi
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

4.  Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism.

Authors:  Marie-France Penet; Balaji Krishnamachary; Flonne Wildes; Yelena Mironchik; Delia Mezzanzanica; Franca Podo; Max de Reggi; Bouchra Gharib; Zaver M Bhujwalla
Journal:  Front Oncol       Date:  2016-11-16       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.